A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight, according to a study ...

Hematopoietic stem cell transplant (HSCT) after first complete remission appears more effective than non-HSCT consolidation in older patients with AML.

Investigators assessed whether intravesical BCG is necessary for patients with high-grade T1 nonmuscle-invasive bladder cancer who have unremarkable histology on the second transurethral resection.

Medicaid expansion was associated with a slower decrease in receipt of guideline-concordant treatment, reduced delays in treatment initiation, and improved 2-year survival, according to researchers.

Most people erroneously think pancreatic cancer occurs only in older people and that they cannot alter risk. HealthDay News — Most people continue to believe that pancreatic cancer affects only the ...

Ravi B Parikh, MD, MPP discusses the current and future use of artificial intelligence (AI) in the greater US health care ...

With a median follow-up duration of 55 months, the tandem ASCT group had a median PFS of 42 months compared with 62 months in the single ASCT group. In a real-world study involving patients with ...

Chemotherapy was associated with short-term cognitive dysfunction after treatment completion among patients with breast cancer. These findings were published in The Oncologist. Chemotherapy-induced ...

Lack of insurance accounts for significant proportion of racial, ethnic disparities in stage III to IV diagnoses across range of cancers.

The 5-year disease-free survival rate was 63.3% for patients with microsatellite instability and 41.4% for patients with microsatellite-stable disease. Microsatellite instability (MSI) is a “striking” ...

Physical function assessments with TUG and SPPB did not identify a decline in function among patients with CRPC receiving darolutamide over 24 weeks.